| Literature DB >> 28249906 |
Alexander J A Deutsch1, Beate Rinner2, Martin Pichler3, Katharina Prochazka4, Katrin Pansy4, Marco Bischof4, Karoline Fechter4, Stefan Hatzl4, Julia Feichtinger5,6, Kerstin Wenzl4, Marie-Therese Frisch2, Verena Stiegelbauer3, Andreas Prokesch7, Anne Krogsdam8, Heinz Sill4, Gerhard G Thallinger5,6, Hildegard T Greinix4, Chenguang Wang9, Christine Beham-Schmid10, Peter Neumeister4.
Abstract
Nuclear orphan receptor NR4A1 exerts an essential tumor suppressor function in aggressive lymphomas. In this study, we investigated the hypothesized contribution of the related NR4A family member NR4A3 to lymphomagenesis. In aggressive lymphoma patients, low expression of NR4A3 was associated with poor survival. Ectopic expression or pharmacological activation of NR4A3 in lymphoma cell lines led to a significantly higher proportion of apoptotic cells. In a mouse NSG xenograft model of lymphoma (stably transduced SuDHL4 cells), NR4A3 expression abrogated tumor growth, compared with vector control and uninduced cells that formed massive tumors. Transcript analysis of four different aggressive lymphoma cell lines overexpressing either NR4A3 or NR4A1 revealed that apoptosis was driven similarly by induction of BAK, Puma, BIK, BIM, BID, and Trail. Overall, our results showed that NR4A3 possesses robust tumor suppressor functions of similar impact to NR4A1 in aggressive lymphomas. Cancer Res; 77(9); 2375-86. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28249906 DOI: 10.1158/0008-5472.CAN-16-2320
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701